Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease . a case-control study
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationDement Geriatr Cogn Disord. 1998, 9(5):239-42
AbstractThe copper-containing enzyme superoxide dismutase (SOD) is a key enzyme in suppressing the amounts of superoxide anion radicals. Ceruloplasmin, the copper-transporting protein in plasma, also possesses an important redox capacity. In this study the levels of copper and ceruloplasmin as well as SOD-activity and ceruloplasmin oxidative activity were analyzed in order to throw some light on possible defects in copper mechanisms in patients diagnosed with Alzheimer's disease (AD). The study included 44 patients with AD and their healthy age- and gender-matched controls. No difference of significance was seen when comparing the copper or ceruloplasmin concentration in plasma of AD patients to that of their paired controls. The SOD activity in red blood cells was significantly lower in the patients than in their controls (p = 0.019). The ceruloplasmin oxidative activity in plasma of Alzheimer's patients was greatly reduced as compared to that of age- and gender-matched controls and the difference was highly significant (p = 0.0005). Ceruloplasmin activity and SOD activity were not found to be intrinsically correlated. It was postulated that reduced oxidative activity of ceruloplasmin in plasma might be either a cause or a consequence of AD and that reduced SOD activity might further add to the oxidative disturbances in AD due to defective ceruloplasmin activity.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Copper, ceruloplasmin and superoxide dismutase (SOD) in amyotrophic lateral sclerosis.
- Authors: Tórsdóttir G, Kristinsson J, Gudmundsson G, Snaedal J, Jóhannesson T
- Issue date: 2000 Sep
- Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.
- Authors: Tórsdóttir G, Kristinsson J, Sveinbjörnsdóttir S, Snaedal J, Jóhannesson T
- Issue date: 1999 Nov
- Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome.
- Authors: Tórsdóttir G, Kristinsson J, Hreidarsson S, Snaedal J, Jóhannesson T
- Issue date: 2001 Dec
- Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.
- Authors: Park JH, Lee DW, Park KS
- Issue date: 2014 Mar
- Copper and zinc concentrations and the activities of ceruloplasmin and superoxide dismutase in atherosclerosis obliterans.
- Authors: Iskra M, Majewski W
- Issue date: 2000 Jan